Julie Papanek is Director at Protagonist Therapeutics, Inc (PTGX). They have made 1 open-market trade across 1 company since 2016, most recently 2016-08-16.
CIK 0001377121
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $7.0M since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PTGX | 1,869,922 | $268.1M |
Shares reported on the most recent Form 4, priced at the 2016-08-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PTGX | BUY | 2016-08-16 | 2016-08-16 | $12.00 | $7.0M | -9.8% | +15.0% | +108.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.